Madison Avenue Partners, LP - Mar 25, 2025 SCHEDULE 13G Report for Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

Filing Manager
Madison Avenue Partners, LP
Reporting Manager
Madison Avenue International LP
Security
Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock")
Symbol
SAGE
Shares outstanding
61.5M shares
Disclosed Ownership
4.92M shares
Ownership
8%
Form type
SCHEDULE 13G
Date filed
4/1/2025, 05:35 PM
Date of event
Mar 25, 2025
Next filing
Aug 14, 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Madison Avenue International LP 8% 4.92M 0 4.92M /s/ Eli Samaha Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP
Madison Avenue Partners, LP 8% 4.92M 0 4.92M /s/ Eli Samaha Eli Samaha, as Managing Member of EMAI Management, LLC, the General Partner of Madison Avenue Partners, LP
EMAI Management, LLC 8% 4.92M 0 4.92M /s/ Eli Samaha Eli Samaha, as Managing Member
Madison Avenue GP, LLC 8% 4.92M 0 4.92M /s/ Eli Samaha Eli Samaha, as Manager
Caraway Jackson Investments LLC 8% 4.92M 0 4.92M /s/ Eli Samaha Eli Samaha, as Member
Eli Samaha 8% 4.92M 0 4.92M /s/ Eli Samaha Eli Samaha